ALI DENKTAS to United States
This is a "connection" page, showing publications ALI DENKTAS has written about United States.
Connection Strength
0.252
-
Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry. JACC Cardiovasc Interv. 2008 Oct; 1(5):504-10.
Score: 0.026
-
2023 ACC/AHA/SCAI advanced training statement on interventional cardiology (coronary, peripheral vascular, and structural heart interventions): A report of the ACC Competency Management Committee. J Thorac Cardiovasc Surg. 2023 09; 166(3):e73-e123.
Score: 0.018
-
2023 ACC/AHA/SCAI Advanced Training Statement on Interventional Cardiology (Coronary, Peripheral Vascular, and Structural Heart Interventions): A Report of the ACC Competency Management Committee. JACC Cardiovasc Interv. 2023 05 22; 16(10):1239-1291.
Score: 0.018
-
2023 ACC/AHA/SCAI Advanced Training Statement on Interventional Cardiology (Coronary, Peripheral Vascular, and Structural Heart Interventions): A Report of the ACC Competency Management Committee. Circ Cardiovasc Interv. 2023 04; 16(4):e000088.
Score: 0.018
-
2023 ACC/AHA/SCAI Advanced Training Statement on Interventional Cardiology (Coronary, Peripheral Vascular, and Structural Heart Interventions): A Report of the ACC Competency Management Committee. J Am Coll Cardiol. 2023 04 11; 81(14):1386-1438.
Score: 0.018
-
Readmission in patients undergoing percutaneous patent foramen ovale closure in the United States. Int J Cardiol. 2023 Jan 01; 370:143-148.
Score: 0.017
-
Mortality differences among patients with in-hospital ST-elevation myocardial infarction. Clin Cardiol. 2020 Dec; 43(12):1555-1561.
Score: 0.015
-
Outcomes of Reoperative Coronary Artery Bypass Graft Surgery in the United States. J Am Heart Assoc. 2020 08 04; 9(15):e016282.
Score: 0.015
-
Temporal Trends and Outcomes of Percutaneous Coronary Atherectomy in the United States. J Invasive Cardiol. 2020 05; 32(5):E110-E121.
Score: 0.015
-
Temporal trends, outcomes, and predictors of mortality after pericardiocentesis in the United States. Catheter Cardiovasc Interv. 2020 02 15; 95(3):375-386.
Score: 0.014
-
Outcomes of Veterans Undergoing TAVR Within Veterans Affairs Medical Centers: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. JACC Cardiovasc Interv. 2019 11 11; 12(21):2186-2194.
Score: 0.014
-
2019 ACC/AHA/ASE Advanced?Training Statement on Echocardiography (Revision of the 2003 ACC/AHA Clinical Competence Statement on Echocardiography): A Report of the ACC Competency Management Committee. J Am Soc Echocardiogr. 2019 08; 32(8):919-943.
Score: 0.014
-
Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry. J Am Heart Assoc. 2018 06 09; 7(12).
Score: 0.013
-
Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease. Am J Cardiol. 2016 Oct 15; 118(8):1144-1149.
Score: 0.011
-
Comparison of the use of hemodynamic support in patients =80 years versus patients <80 years during high-risk percutaneous coronary interventions (from the Multicenter PROTECT II Randomized Study). Am J Cardiol. 2014 Sep 01; 114(5):657-64.
Score: 0.010
-
Comparison of outcomes for patients =75 years of age treated with pre-hospital reduced-dose fibrinolysis followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction. Am J Cardiol. 2014 Jan 01; 113(1):60-3.
Score: 0.009
-
Prehospital Fibrinolysis in concert with rapid PCI. Clinical trial shows promising results for use of clot-dissolving agents in the field. JEMS. 2008 Mar; 33(3):74-88.
Score: 0.006